EUCTR2012-002835-27-AT进行中(未招募)不适用
Double-blind, randomized clinical study to determine the efficacy of Anestherit® 10% on histamine-induced pruritus and UVB-light induced slight sunburn in healthy subjects.
Dr. Ritsert Pharma0 个研究点开始时间: 2012年8月13日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中(未招募)
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Male
入选标准
- •Age: ? 18 and ? 45 years
- •Body Mass Index of 19.0 – 29.0 (kg/m2)
- •Male healthy subjects
- •Subject able and willing to sign informed consent
- •No antecedents of atopic, allergic or neurological disease within three months prior to the study
- •No skin lesions or scars on the tested area and around (within 5 cm from the tested area)
- •No use of cosmetics, ointment or cream on the studied areas from one week prior to the initiation of test
- •No anti-inflammatory drug within one week prior to the study
- •No anti-histamines within three weeks prior to the study
- •No systematic antiallergic medication 7 days prior to the study
- •No topical emollient preparation 14 days prior to the study
- •No topical or systemic steroids 1 months prior to the study
- •No psychopharmacological drugs 1 year prior to the study
- •Non-smoker (more than one year)
- •No intake of drugs known for inducing photosensitivity (e.g. Thioxanthenes (chlorprothixene, thiothixene), Antifungals, Itraconazole, Voriconazole, 5-Fluorouracil, Amiodarone, Diltiazem, Quinidine, Enalapril, Dapsone, Cinnamates, Salicylates)
- •No large-area tattoo or skin lesions (e.g. cicatrice) on forearms or upper back
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 20
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Unable to meet inclusion criteria.
- •Any concomitant illness or abnormal laboratory test which, in the investigator's opinion, would render the subject unsuitable for enrolment.
- •History of alcohol or drug abuse.
- •Known hypersensitivity to the product or excipients.
- •Other therapy that excludes the use of study treatment.
- •Participation in other clinical trials within the past 1 month.
- •Subjects with psoriasis, neurodermatitis or eczema.
- •Subjects treated with corticoids, cytotoxic drugs, cancer, HIV
- •The family of the investigators and the sponsor.
研究者
相似试验
尚未招募
3 期
A randomized, double-blind clinical study to evaluate the efficacy and safety of Cephalexin 250mg + Ambroxol hydrochloride 15mg (Cefabroncol®, powder for suspension) compared to Cephalexin 250mg (powder for suspension) in pediatric patients with Acute Bacterial Pharyngotonsillitis.J030 Streptococcal tonsillitisStreptococcal tonsillitisJ030PER-030-22MEDIFARMA S A
已完成
不适用
Efficacy of novel blended diet (BE22001) compared with conventional diet in improving the well-being of healthy adultsCTRI/2022/10/046112B2E Foods Private Limited40
已完成
不适用
Greeva basti in viswachiCTRI/2021/04/032654shri Dharamasthala Manjunatheshwara college of ayurveda and hospital30
已完成
不适用
Effect of gamma oryzanol on immunity in healthy volunteersCTRI/2021/03/031920AP Organics Limited30
暂停
不适用
Effect of gamma oryzanol on immunity and cognition in healthy volunteersCTRI/2021/07/035080AP Organics Limited
